Data / Drug companies / Aminocaproic acid
Aminocaproic acid: 23 companies and 37 products in the FDA NDC directory
Aminocaproic acid is listed in the FDA National Drug Code Directory by 23 companies, with 37 products in commercial distribution. 35 of the products (94.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; injection, solution, and the newest product started marketing on September 20, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 23
- Products
- 37
- Generic (ANDA) products
- 35 (94.6%)
- Application numbers
- 19
- Routes
- Oral, Intravenous
- openFDA record search
- api.fda.gov
Companies that list aminocaproic acid
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Biocon Pharma Inc. | 3 | tablet; solution | Generic drugs (ANDA) | March 18, 2021 |
| Carnegie Pharmaceuticals LLC | 3 | tablet; solution | Generic drugs (ANDA) | March 18, 2021 |
| Novadoz Pharmaceuticals LLC | 3 | tablet; solution | Generic drugs (ANDA) | September 26, 2024 |
| Vitruvias Therapeutics | 3 | tablet; solution | Generic drugs (ANDA) | July 19, 2024 |
| American Regent, Inc. | 2 | injection, solution | Generic drugs (ANDA) | February 1, 2019 |
| Amneal Pharmaceuticals NY LLC | 2 | solution; tablet | Generic drugs (ANDA) | November 30, 2019 |
| Hikma Pharmaceuticals USA Inc. | 2 | syrup; tablet | Authorized generics (NDA) | March 12, 2019 |
| Medical Purchasing Solutions, LLC | 2 | injection, solution | Generic drugs (ANDA) | May 12, 2010 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | January 24, 2023 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Generic drugs (ANDA) | September 20, 2026 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | March 10, 2023 |
| Apozeal Pharmaceuticals Inc | 1 | solution | Generic drugs (ANDA) | November 10, 2025 |
| Aurobindo Pharma Limited | 1 | solution | Generic drugs (ANDA) | September 26, 2022 |
| Bpi Labs LLC | 1 | solution | Generic drugs (ANDA) | May 16, 2022 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | March 18, 2021 |
| Camber Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | November 4, 2022 |
| Civica, Inc. | 1 | injection, solution | Generic drugs (ANDA) | October 29, 2020 |
| Florida Pharmaceutical Products, LLC | 1 | solution | Generic drugs (ANDA) | December 20, 2025 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | October 26, 2021 |
| Hospira, Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 12, 2010 |
| Kesin Pharma Corporation | 1 | tablet | Generic drugs (ANDA) | December 10, 2020 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | November 30, 2019 |
| TruPharma, LLC | 1 | solution | Generic drugs (ANDA) | September 25, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 17 | 45.9% |
| Solution | 12 | 32.4% |
| Injection, solution | 7 | 18.9% |
| Syrup | 1 | 2.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 35 | 94.6% |
| Authorized generics (NDA) | 2 | 5.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antifibrinolytic Agent | 37 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.